Showing results (411-420 of 1,062) with videos related to
Sort By:
Pageof 107
Alzheimer'S & Dementia (New York, N. Y.)|February 10, 2022
Gamma-induction in frontotemporal dementia (GIFTeD) randomized placebo-controlled trial: Rationale, noninvasive brain stimulation protocol, and study designMartina Assogna, Giulia Sprugnoli, Daniel Press, et al.Alzheimer'S & Dementia (New York, N. Y.)|March 21, 2022
VALZ-Pilot: High-dose valacyclovir treatment in patients with early-stage Alzheimer's diseaseBodil Weidung, Eva-Stina Hemmingsson, Jan Olsson, et al.Alzheimer'S & Dementia (New York, N. Y.)|March 21, 2022
Risk of conversion from mild cognitive impairment to dementia in low- and middle-income countries: A systematic review and meta-analysisAndrea M McGrattan, Eduwin Pakpahan, Mario Siervo, et al.Alzheimer'S & Dementia (New York, N. Y.)|March 21, 2022
Care transitions intervention reduces ED revisits in cognitively impaired patientsManish N Shah, Gwen C Jacobsohn, Courtney Mc Jones, et al.Alzheimer'S & Dementia (New York, N. Y.)|April 27, 2022
Association of vitamin K with cognitive decline and neuropathology in community-dwelling older personsSarah L Booth, M Kyla Shea, Kathryn Barger, et al.Alzheimer'S & Dementia (New York, N. Y.)|April 13, 2022
Loss of corneal nerves and brain volume in mild cognitive impairment and dementiaGeorgios Ponirakis, Hanadi Al Hamad, Adnan Khan, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 9, 2018
Network-based assessment of collaborative research in neuroscienceGwen C Marchand, Jonathan C Hilpert, Kristine M Bragg, et al.Alzheimer'S & Dementia (New York, N. Y.)|June 14, 2019
Enrichment factors for clinical trials in mild-to-moderate Alzheimer's diseaseClive Ballard, Alireza Atri, Neli Boneva, et al.Alzheimer'S & Dementia (New York, N. Y.)|May 9, 2019
A model of lipid dysregulation and altered nutrient status in Alzheimer's diseaseKeith FlueggeAlzheimer'S & Dementia (New York, N. Y.)|September 28, 2018
Cognitive and structural cerebral changes in amnestic mild cognitive impairment due to Alzheimer's disease after multicomponent trainingCamila Vieira Ligo Teixeira, Thiago Junqueira Ribeiro de Rezende, Marina Weiler, et al.Pageof 107